Limitations of using outcomes in the placebo arm of a clinical trial of benign prostatic hyperplasia to quantify those in the community.

R. Roberts,M. Lieber,D. Jacobson,C. Girman,S. Jacobsen
DOI: https://doi.org/10.1016/S0025-6196(11)61530-9
IF: 11.104
2005-06-01
Mayo Clinic Proceedings
Abstract:
What problem does this paper attempt to address?